Susquehanna International Group
DERM icon

Susquehanna International Group’s Journey Medical DERM Stock Holding History

Susquehanna International Group’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59.7K Buy
12,721
+472
+4% +$3.66K ﹤0.01% 12584
2025
Q4 		$94.4K Buy
+12,249
New +$96K ﹤0.01% 11486
2025
Q3 		– Sell
-15,388
Closed -$110K – 12651
2025
Q2 		$110K Sell
15,388
-41,951
-73% -$290K ﹤0.01% 11728
2025
Q1 		$338K Buy
57,339
+38,617
+206% +$190K ﹤0.01% 9792
2024
Q4 		$73.2K Buy
+18,722
New +$102K ﹤0.01% 11515
2022
Q4 		– Sell
-22,094
Closed -$54K – 12638
2022
Q3 		$54K Buy
+22,094
New +$75.3K ﹤0.01% 12146

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's DERM Position: Q1 2026 in Review

Susquehanna International Group increased its Journey Medical (DERM) stake by 3.9% in Q1 2026, buying an estimated $3.66K and bringing the position to 12,721 shares worth $59.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12584.

Susquehanna International Group first reported a position in DERM in Q3 2022 and has held it in 6 quarters since. The position peaked at $338K in Q1 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Susquehanna International Group held 12,721 shares of Journey Medical worth $59.7K as of Q1 2026.
  • Susquehanna International Group bought 472 Journey Medical shares in Q1 2026, an estimated $3.66K.
  • Journey Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12584 holding.
  • Susquehanna International Group first reported a position in Journey Medical in Q3 2022 and has held it in 6 quarters since.
  • Susquehanna International Group's Journey Medical position peaked at $338K in Q1 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.